Katarzyna Tomczak

Sep 6, 2024 | digitalcommons.library.tmc.edu | Nathaniel Deboever |Nicolas Zhou |Daniel J. McGrail |Katarzyna Tomczak

BACKGROUND: Malignant pleural mesothelioma (MPM) is associated with poor prognosis despite advances in multimodal therapeutic strategies. While patients with resectable disease may benefit from added survival with oncologic resection, patient selection for mesothelioma operations often relies on both objective and subjective evaluation metrics.

Jul 21, 2023 | nature.com | Huihui Fan |Dapeng Hao |Fatima Zahra Jelloul |Ken Chen |Zhongming Zhao |Kunal Rai | +3 more

Human subjects and treatment regimenBone marrows from eight adult (>=18 years of age) patients on NCT02397720 protocol were included in this study. All patients had histologically proved relapsed or refractory acute myeloid leukemia. Timepoint A was collected at the time of proven relapse or primary refractoriness.